Former White House coronavirus task force spokesman Ambassador Deborah Birx has effectively laid the blame for thousands of deaths at the door of big pharmaceutical giants Pfizer and Moderna, claiming their refusal to pursue a “compassionate use authorization” for the COVID-19 vaccines led to a delay which directly impacted nursing home residents, The National Pulse can reveal.
The details come in the final parts of Birx’s little read book – Silent Invasion – wherein she details how she used “subterfuge” to get around the will of the Trump administration, as well as naming Trump son-in-law Jared Kushner and Vice President Mike Pence as her “go to” people in the government.
In Chapter 19, entitled “Winter Is Here,” Birx turns her guns on the same pharmaceutical companies she and her colleague Anthony Fauci promoted and protected during the COVID-19 outbreak. Specifically, she points out that the corporates who were shielded by the government from liability failed to get vital doses of their vaccines into the arms of those who needed it earliest: the elderly:
“Getting as many people inoculated as quickly and equitably as possible remained one of my priorities. In addition to “emergency use authorization,” or EUA, the FDA also has the authority to allow the use of therapeutics and vaccines (and the use of experimental drugs to people outside clinical trials) under what’s called “compassionate use authorization,” or CUA. Lacking the holy grail of emergency use authorization (which was pending), I continued to try to find a way to get the highest-risk group immunized as quickly as possible. In early November, I asked Tony and Steve to approach Moderna and Pfizer and urge them to apply for CUA while their vaccines’ efficacy was still being determined but safety was fairly clear. With a CUA in hand, we could inoculate any nursing home residents who wished to be. Whether they volunteered for the jabs or not, at least they’d have the option.”
But as many continued to die, her wishes were not carried through, she explains:
“We had a narrow window, and it was closing. Fifteen hundred nursing home residents died in the first week of October. The vaccine manufacturers, I learned, had already stockpiled three million doses. If we could draw from that supply through CUA, thousands of lives could be saved.
“This didn’t happen. Pfizer and Moderna declined to pursue compassionate use authorization. They believed the process would be a distraction. Their eyes were fixed on the EUA, another complicated process; taking on both simply wasn’t possible.
“I believed it was—it just wasn’t part of the plan these manufacturers had envisioned.”
Birx then goes on to detail the number of people that were affected by the major corporations’ refusal to pursue a faster route to market. At the time, many suspected they were refusing to do so because the such speed would give President Trump an ostensible boost right before the U.S. presidential election.
“Take a moment to imagine that they did apply for compassionate use. And imagine that 1.5 million of the 3 million stockpiled doses went to nursing homes in November, and another 1.5 million at the end of November, for a second dose. If this had happened, the nursing home residents would have been fully protected in December, at the start of the surge, and not, as it turned out, as late as February, after the surge. An additional six-thousand-plus nursing home residents died in mid-December. They all could have been fully immunized and protected before this happened and we could have saved thousands of lives. If this had been done, literally thousands of lives could have been saved. Great good could have been done, and at low risk to these vulnerable people. In a pandemic, you need to innovate on the fly in response to the reality of the moment and not be locked into a rigid plan.”